about
Structural basis for activation of the complement system by component C4 cleavageA noncoding expansion in EIF4A3 causes Richieri-Costa-Pereira syndrome, a craniofacial disorder associated with limb defectsStructural insights into the oligomerization mode of the human receptor for advanced glycation end-productsStructural basis for the function of DEAH helicasesStructure of and influence of a tick complement inhibitor on human complement component 5Structural basis for receptor recognition of vitamin-B(12)-intrinsic factor complexesThe crystal structure of human α2-macroglobulin reveals a unique molecular cageStructural insight on the recognition of surface-bound opsonins by the integrin I domain of complement receptor 3Structure of the haptoglobin-haemoglobin complexThe specificity of DNA recognition by the RAGE receptorStructural and functional characterization of human and murine C5a anaphylatoxinsStructural Basis for the Function of Complement Component C4 within the Classical and Lectin Pathways of ComplementStructural Basis for Eculizumab-Mediated Inhibition of the Complement Terminal PathwayRe-evaluation of low-resolution crystal structures via interactive molecular-dynamics flexible fitting (iMDFF): a case study in complement C4The structure of bovine complement component 3 reveals the basis for thioester functionExpression in Escherichia coli: purification and characterization of cyclin H, a subunit of the human general transcription/DNA repair factor TFIIHLow-resolution X-ray diffraction data obtained from hexagonal crystals of methylamine-treated alpha2-macroglobulin.Mutations in complement C3 from aHUS patients.Complement activation by ligand-driven juxtaposition of discrete pattern recognition complexes.Low resolution X-ray structure of human methylamine-treated alpha 2-macroglobulin.Synergistic activation of eIF4A by eIF4B and eIF4G.α2-Macroglobulin Can Crosslink Multiple Plasmodium falciparum Erythrocyte Membrane Protein 1 (PfEMP1) Molecules and May Facilitate Adhesion of Parasitized Erythrocytes.Crystal structure of human S100A8 in complex with zinc and calcium.Structure, function and control of complement C5 and its proteolytic fragments.Toward a structure-based comprehension of the lectin pathway of complement.Toward a structure-based comprehension of the lectin pathway of complement.Structural basis for the targeting of complement anaphylatoxin C5a using a mixed L-RNA/L-DNA aptamer.Protein glutaminylation is a yeast-specific posttranslational modification of elongation factor 1A.Structural insight into proteolytic activation and regulation of the complement system.Structure of the omalizumab Fab.Structure of the DEAH/RHA ATPase Prp43p bound to RNA implicates a pair of hairpins and motif Va in translocation along RNA.Functional and structural insight into properdin control of complement alternative pathway amplification.Structural Basis for Simvastatin Competitive Antagonism of Complement Receptor 3.Structure and activation of C1, the complex initiating the classical pathway of the complement cascade.Structural insights into the initiating complex of the lectin pathway of complement activation.Introducing site-specific cysteines into nanobodies for mercury labelling allows de novo phasing of their crystal structures.Solution Structures of Complement C2 and Its C4 Complexes Propose Pathway-specific Mechanisms for Control and Activation of the Complement Proconvertases.Mimer: an automated spreadsheet-based crystallization screening system.Structural analysis of RNA helicases with small-angle X-ray scattering.Trapping IgE in a closed conformation by mimicking CD23 binding prevents and disrupts FcεRI interaction.
P50
Q24298033-897826B7-0A3A-4757-B504-42081813DBCCQ24315833-A79D4173-C1A6-4DED-A473-57A1A245D84BQ24338271-710CDA37-7244-4670-8420-3920584FB913Q27491211-23C7D20A-EBCC-4C27-90BD-25D7E32F8B95Q27650767-A0158A3E-D0B1-4A7A-A074-28DEDE300AEBQ27660268-B9C4840D-B233-48D3-9E8E-E8F8E844B878Q27676954-B712A4EE-070F-44BB-909B-1D38C58DC8A0Q27680051-E002371B-E649-4F3C-A0B2-69B0356B35EAQ27682043-C9252770-C23A-468A-8D4E-F101E1D12F7EQ27683591-8360388B-59C9-4EFE-90CD-2C2F98F85DC5Q27684270-9819D17D-2791-4D49-9EFD-34911D8221C4Q27700252-B1493419-C2C3-4284-80CD-E91B271FDAD1Q27704898-29EEC81D-71C4-4248-B6CA-932DA5A308E3Q27728011-41936236-FEFD-4685-8AB3-56E4A5938A4BQ28251146-0F68BAC0-31AA-424A-ACC8-80BE6139B6A1Q28305079-E146B212-F656-47CF-A6F6-CB969E8DC972Q33205559-D668D844-9EBE-454C-AE00-BBC9FA806BEFQ33421849-E2EAFE0F-1153-4B2C-B9B0-2531EF3749F9Q34218280-96149724-20D8-42BB-9B22-05AD36EA1F00Q34295583-F24B7801-9F01-427E-A01D-B7725AA902EFQ34779422-34F544F4-70BE-433F-857D-B54627EF87A5Q35811289-E7F2F224-D6BD-4479-8650-504DE1C6FD71Q36037145-7FFE6734-912D-4585-8EF0-7693F66AF25AQ38027557-65010752-7C79-4B00-8778-80313460E70AQ38117938-213262DA-6DBD-4902-8B90-6F729A2D17ADQ38126258-7B9FA7C7-7AE1-4BA3-A35C-2F3A5FF96C7CQ38299564-B3714C53-BD25-4666-8C0B-DE5DA3DA51A3Q38628200-DC0341E9-C1BB-4F0F-A544-D4930ADFAA73Q38991069-F2634832-EBD5-4EF8-B211-D197B4FE3149Q39335284-48BF82E6-5EF3-4C7A-A670-84C66B9C4C24Q40239505-F56526A7-7AE5-4AB8-A410-3F70FE5C041DQ40306147-0796D387-E3D0-4FAA-91F7-B2D68772EEA9Q40638258-B09DBED7-22CF-435D-A1E6-744D7A96C27EQ41892253-6E59439D-5D9E-45AD-B76D-9CADA1A29174Q42152334-3C45DE15-2558-430C-81E6-F847987D1637Q42267711-7373BEE5-0192-48CC-BF1A-8D87C81D6BF8Q42380135-4BDDD929-3C85-4C62-8B12-F56292A7769AQ43105197-FB867908-2EDA-4CE9-BB86-49473C026178Q43553472-870543DC-D6B3-4A89-9ED3-B2945C23FCECQ47203998-635D1432-8475-4FD3-AC5E-49763E696E3D
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Gregers R Andersen
@nl
Gregers R Andersen
@sl
Gregers R. Andersen
@en
Gregers R. Andersen
@es
type
label
Gregers R Andersen
@nl
Gregers R Andersen
@sl
Gregers R. Andersen
@en
Gregers R. Andersen
@es
prefLabel
Gregers R Andersen
@nl
Gregers R Andersen
@sl
Gregers R. Andersen
@en
Gregers R. Andersen
@es
P106
P1153
57200145675
P21
P31
P496
0000-0001-6292-3319